BACKGROUND: The infant Jarvik 2000 heart is a very small, hermetically sealed, intracorporeal, axial-flow ventricular assist device (VAD) designed for circulatory support in neonates and infants. The anatomic fit, short-term biocompatibility and hemodynamic performance of the device were evaluated in a neonate piglet model. METHODS: The infant Jarvik 2000 heart with two different blade profiles (low- or high-flow blade design) was tested in 6 piglets (8.8 ± 0.9 kg). Using a median sternotomy, the pump was placed in the left ventricle through the apex without cardiopulmonary bypass. An outflow graft was anastomosed to the ascending aorta. Hemodynamics and biocompatibility were studied for 6 hours. RESULTS: All 6 pumps were implanted without complication. Optimal anatomic positioning was found with the pump body inserted 2.4 cm into the left ventricle. Hemodynamics demonstrated stability throughout the 6-hour duration. The pump flow increased from 0.27 to 0.95 liter/min at increasing speeds from 18 to 31 krpm for the low-flow blade design, whereas the pump flow increased from 0.54 liter/min to 1.12 liters/min at increasing speeds from 16 krpm to 31 krpm for the high-flow blade design. At higher speeds, >80% of flow could be supplied by the device. Blood chemistry and final pathology demonstrated no acute organ injury or thrombosis for either blade design. CONCLUSIONS: The infant Jarvik 2000 heart is anatomically and biologically compatible with an short-term neonate piglet model. This in vivo study demonstrates the future feasibility of this device for clinical use.
BACKGROUND: The infant Jarvik 2000 heart is a very small, hermetically sealed, intracorporeal, axial-flow ventricular assist device (VAD) designed for circulatory support in neonates and infants. The anatomic fit, short-term biocompatibility and hemodynamic performance of the device were evaluated in a neonate piglet model. METHODS: The infant Jarvik 2000 heart with two different blade profiles (low- or high-flow blade design) was tested in 6 piglets (8.8 ± 0.9 kg). Using a median sternotomy, the pump was placed in the left ventricle through the apex without cardiopulmonary bypass. An outflow graft was anastomosed to the ascending aorta. Hemodynamics and biocompatibility were studied for 6 hours. RESULTS: All 6 pumps were implanted without complication. Optimal anatomic positioning was found with the pump body inserted 2.4 cm into the left ventricle. Hemodynamics demonstrated stability throughout the 6-hour duration. The pump flow increased from 0.27 to 0.95 liter/min at increasing speeds from 18 to 31 krpm for the low-flow blade design, whereas the pump flow increased from 0.54 liter/min to 1.12 liters/min at increasing speeds from 16 krpm to 31 krpm for the high-flow blade design. At higher speeds, >80% of flow could be supplied by the device. Blood chemistry and final pathology demonstrated no acute organ injury or thrombosis for either blade design. CONCLUSIONS: The infant Jarvik 2000 heart is anatomically and biologically compatible with an short-term neonate piglet model. This in vivo study demonstrates the future feasibility of this device for clinical use.
Authors: Richard Kirk; Leah B Edwards; Paul Aurora; David O Taylor; Jason Christie; Fabienne Dobbels; Anna Y Kucheryavaya; Axel O Rahmel; Marshall I Hertz Journal: J Heart Lung Transplant Date: 2008-09 Impact factor: 10.247
Authors: Stephen Westaby; Adrian Banning; Desley Neil; Philip Poole-Wilson; O Howard Frazier Journal: J Thorac Cardiovasc Surg Date: 2009-03-17 Impact factor: 5.209
Authors: David L S Morales; Farhan Zafar; Joseph W Rossano; Jorge D Salazar; John L Jefferies; Daniel E Graves; Jeffrey S Heinle; Charles D Fraser Journal: Ann Thorac Surg Date: 2010-10 Impact factor: 4.330
Authors: David L S Morales; Christopher S D Almond; Robert D B Jaquiss; David N Rosenthal; David C Naftel; M Patricia Massicotte; Tilman Humpl; Mark W Turrentine; James S Tweddell; Gordon A Cohen; Robert Kroslowitz; Eric J Devaney; Charles E Canter; Francis Fynn-Thompson; Olaf Reinhartz; Michiaki Imamura; Nancy S Ghanayem; Holger Buchholz; Sarah Furness; Robert Mazor; Sanjiv K Gandhi; Charles D Fraser Journal: J Heart Lung Transplant Date: 2011-01 Impact factor: 10.247
Authors: Douglas Mah; Tajinder P Singh; Ravi R Thiagarajan; Kimberlee Gauvreau; Gary E Piercey; Elizabeth D Blume; Francis Fynn-Thompson; Christopher S D Almond Journal: J Heart Lung Transplant Date: 2009-09-26 Impact factor: 10.247
Authors: Brody Wehman; Kristen A Stafford; Gregory J Bittle; Zachary N Kon; Charles F Evans; Keshava Rajagopal; Nicholas Pietris; Sunjay Kaushal; Bartley P Griffith Journal: Ann Thorac Surg Date: 2016-02-22 Impact factor: 4.330
Authors: Thomas Palazzolo; Matthew Hirschhorn; Ellen Garven; Steven Day; Randy M Stevens; Joseph Rossano; Vakhtang Tchantchaleishvili; Amy L Throckmorton Journal: Artif Organs Date: 2022-04-14 Impact factor: 2.663
Authors: Viola Kooij; Vidya Venkatraman; John Tra; Jonathan A Kirk; Janelle Rowell; Anna Blice-Baum; Anthony Cammarato; Jennifer E Van Eyk Journal: Proteomics Clin Appl Date: 2014-06-25 Impact factor: 3.494